Work

Inappropriate Use of the Same Cutoff by Different Sequencing Panels for Tumor Mutation Burden as Immunotherapy Biomarker—Reply

Year: 2021

Type: letter

Source: JAMA Oncology

DOI: 10.1001/jamaoncol.2021.1870

Authors: Cristina Valero, Timothy A. Chan, Luc G. T. Morris

Institutions: Memorial Sloan Kettering Cancer Center, Cleveland Clinic, Cleveland Clinic Research

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3170490029

Cites: 5

Cited by:

Related to: 10